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Abstract Breath is considered to be an easily accessible
matrix, whose chemical composition relates to compounds
present in blood. Therefore many metabolites are expected
in exhaled breath, which may be used in the future for the
development of diagnostic methods. In this article, a new
strategy to discriminate between exhaled endogenous
metabolites and exhaled exogenous contaminants by direct
high-resolution mass spectrometry is introduced. The
analysis of breath in real-time by secondary electrospray
ionization mass spectrometry allows to interpret the origin
of exhaled compounds. Exhaled metabolites that originate
in the respiratory system show reproducible and significant
patterns if plotted in real-time ([1 data point per second).
An exhaled metabolite shows a signal that tends to rise at
the end of a complete (forced) exhalation. In contrast,
exogenous compounds, which may be present in room air,
are gradually diluted by the air from the deeper lung and
therefore show a trend of falling intensity. Signals found in
breath by using this pattern recognition are linked to
potential metabolites by comparison with online databases.
In addition to this real-time approach, it is also shown how
to combine this method with classical analytical methods in
order to potentially identify unknown metabolites. Finally
exhaled compounds following smoking a cigarette, chew-
ing gum, or drinking coffee were investigated to underline
the usefulness of this new approach.
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Abbreviations
APCI Atmospheric pressure chemical ionization
Da Dalton, molecular mass unit g/mol
ECB Exhaled breath condensate
EI-MS Electron impact mass spectrometry
HMDB Human metabolite data base
HPLC High performance liquid chromatography
MS Mass spectrometry
PTR-MS Proton transfer reaction mass spectrometry
SESI Secondary electrospray ionization
SIFT-MS Selected ion flow tube mass spectrometry
SPME Solid phase micro extraction
UPLC Ultra performance liquid chromatography
1 Introduction
An important aspect of modern metabolomics investiga-
tions is the development of diagnostic methodologies and
techniques. One of the key challenges is always the iden-
tification of unknown compounds and potential biological
markers. Metabolomic studies are usually performed using
blood, urine or tissue samples (Fiehn 2002). A quite novel
approach in metabolic research is the use of breath as a
sample. Breath is a matrix that can sampled non-invasively,
has a relatively low level of complexity, and provides
information related to the actual health status. Therefore,
breath is very interesting for metabolomics studies, espe-
cially for the development of diagnostic tests (Buszewski
et al. 2007; Kim et al. 2012).
Breath is composed of atmospheric gases, such as
nitrogen, oxygen and is enriched with carbon dioxide,
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water vapor and nitric oxide in the vol% to ppmV range.
Volatile organic compounds (VOCs), with a boiling point
\100 C and a molecular weight \200 Da, are usually
found in the ppmV–ppbV range (Risby 2008). In addition
to VOCs, compounds of low volatility are also present
among the exhaled metabolites (Cathcart et al. 2012).
These are exhaled in the ppbV–pptV concentration and are
in some cases probably exhaled as aerosols (Johnson and
Morawska 2009). Exhaled VOCs and compounds of low
volatility represent metabolites that can serve as markers
for various diseases (Buszewski et al. 2007; Kim et al.
2012). While the human metabolome consist of more than
200,000 compounds (Fiehn 2002), only about 2,000 VOCs
have been detected in breath In addition to that, a small
number of metabolites of low volatility has also been found
(Effros et al. 2004). In order to gain an overall under-
standing of human metabolism and to access the broadest
range of diagnostic molecules it is necessary to measure
exhaled volatiles as well as compounds of low volatility.
Diagnostic approaches based on exhaled metabolites are
still quite rare although it has been known for centuries that
smell of breath can be used as a diagnostic tool. Acetone in
exhaled breath, as an example of volatiles, is known as a
marker for diabetes. The detection of lactase deficiency
(hypolactasia, lactose intolerance) via exhaled breath is
fairly routine. It is detected by measuring exhaled hydrogen
after lactose consumption (Oberacher et al. 2011). Exhaled
urea is used as a marker for the infection by helicobacter
prioli, and the detection of nitric oxide is used in asthma
therapy (Risby and Solga 2006). Diagnostics based on
breath have been investigated for cancer (Mazzone et al.
2012), COPD (Cazzola and Novelli 2010), or lung
inflammation (Carpagnano et al. 2004), but are currently
not used routinely.
Breath analysis can be divided into off-line and real-
time techniques. The off-line collection of breath can
provide a high level of up-concentration and therefore the
highest sensitivity. Solid-phase micro extraction (SPME) in
combination with gas chromatography (GC) and electron
impact (EI) ionization has to be considered the gold stan-
dard for the analysis of VOCs in exhaled breath. Studies of
exhaled breath by Phillips et al. identified almost 2000
volatile compounds in exhaled breath (Phillips et al. 1999).
For compounds of lower volatility, filters or condensers
have been used. Exhaled breath condensate (EBC), which
is the most important technique to sample compounds of
low volatility in breath, allows to pre-concentrate large
volumes of exhaled breath and is therefore considered to be
a good sampling method for very sensitive measurements
(Beck et al. 2011; Cathcart et al. 2012; Dwyer 2004; Effros
et al. 2004; Hunt 2002). Even viral DNA has been detected
in EBC (Costa et al. 2011). EBC was also used to identify
markers of low volatility such as isoprostane (Shahid et al.
2005) or leukotriene (Wardlaw et al. 1989), which are
related to lung inflammation. Off-line methods provide
high sensitivity and allow investigations of exhaled com-
pounds by chromatographic methods. Therefore, com-
pound identification strategies are similar to ‘‘classical’’
metabolomics using blood or urine.
A number of technical aspects have to be considered for
real-time detection of compounds in exhaled breath. ‘‘Real-
time’’ in this context means that exhaled air is analyzed
breath-by-breath using a time resolution of more than one
scan per second. The classical method for real-time breath
analysis, such as APCI (Benoit et al. 1983) direct EI-MS
(Van den Velde et al. 2008), PTR-MS (Smith and Sˇpanel
2011), or SIFT-MS (Sˇpanel and Smith 2011) are well
suited to monitor compounds with molecular weights
below 200 m/z; for example, metabolites such as isoprene
(Schwoebel et al. 2011), acetone (Thekedar et al. 2009) or
ammonia (Smith et al. 2008) have been monitored. How-
ever, the total number of metabolites detected in real time
is only in the range of about 10–20 (Martinez-Lozano et al.
2011), and metabolites of higher molecular weight
(m/z [ 200) are not accessible with these methods.
Exhaled metabolites of higher molecular weight are
potentially of enormous value. Firstly it is expected that
high molecular weight metabolites are more specific for
certain metabolic pathways. Secondly, if a higher number
of metabolites are detected in real time, the chance of
finding a truly specific biomarker or metabolite pattern is
significantly enhanced. Therefore a new method is needed,
which allows to detected volatiles as well as molecules of
low volatility in real time.
To measure compounds of molecular weights of more
than 200 Da in real time and with good sensitivity (\ppb),
direct ionization methods are needed. Secondary electro-
spray ionization (SESI) and related techniques have been
introduced as matrix-tolerant and efficient ionization
method for the detection of compounds of low volatility in
the gas phase by mass spectrometry (Alberici et al. 2010;
Biasioli et al. 2011; Chen et al. 2009a, b; Huang et al.
2011). The detection limit of SESI–MS was tested for a
variety of mass spectrometers and samples and estimated to
be below pptV (Martinez-Lozano and Fernandez de la
Mora 2009). Accordingly, fatty acids were quantified in
breath and estimated to be in the range of 100 pptV
(Martinez-Lozano et al. 2011). However, it was shown that
the sensitivity of SESI for compounds of low volatility was
about 100 times lower than when measuring them by direct
ESI (Meier et al. 2011). The sensitivity is reduced due to
the reduced ionization probability in the secondary ioni-
zation step (Sinues et al. 2012) and due to Coulomb
repulsion in front of the MS (Meier et al. 2012c). To reduce
this loss, Meier et al. introduced an atmospheric-pressure
ion funnel for SESI, and were able to enhance the
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sensitivity by a factor of &1,000 compared to conventional
SESI (Meier et al. 2012a, c). This system was also
hyphenated to a high-resolution mass spectrometer to reach
a new level of resolution ([100,000) and sensitivity (pptV)
(Meier et al. 2012a, c).
The main goal of this study was to investigate the
potential of this novel ionization stage, interfaced with a
high-resolution mass spectrometer, to discriminate between
endogenous metabolites and exogenous contaminants in
exhaled human breath. A new strategy to achieve this
based on real-time breath patterns was developed. A
combination of manual and automatic identification by the
use of open access databases is proposed to allow tentative
assignments of compounds. The ion source could also be
equipped with an off-line sampling system in order to
perform complementary analyses on the same instrument.
This newly proposed strategy was applied to several
exhaled compounds in breath, e.g. after smoking a ciga-
rette, drinking coffee, or chewing gum.
2 Materials and methods
2.1 Materials and reagents
The calibration mix consisted of caffeine, MRFA (Met-
Arg-Phe-Ala), a component of the ProteoMassTM LTQ/FT-
Hybrid ESI Pos. mode CalMIX, as well as nicotine, all of
which were obtained from Sigma-Aldrich (Buchs, SG,
Switzerland). Norfentanyl, morphine, cocaine, naloxone,
fentanyl, and sufentanil were all obtained from Lipomed
AG (Arlesheim, Switzerland). Methanol and acetic acid
were obtained from Acros Organics (Geel, Belgium).
Nanopure water with a resistivity of [18.1 MX cm was
obtained from a NANOpure water purification system
(Barnstead, IA, USA).
2.2 Samples
Samples were collected from a healthy volunteer (a
member of our research team) For real-time experiments
the person was asked to exhale constantly for about 30 s
after taking a deep breath in order to ventilate the whole
lung. The mouthpiece geometry as well as the size and
shape of the ion funnel inlet limited the flow rate to about
7 L/min. For offline evaluation, about 30 breath strokes
were collected on cotton in the same way. The cigarette
(Parisienne Orange, British American Tobacco Switzer-
land) 4 mg tar, 0.4 mg nicotine) and chewing gum
(strawberry flavor Stimorol, Kraft Foods Schweiz GmbH)
were purchased in a local grocery store. Coffee was a large
espresso brewed with Arabica beans (Lavazza).
2.3 LTQ-FT instrument and SESI-interface
All experiments in this study were conducted on a com-
mercial linear ion trap Fourier-transform ion cyclotron
mass spectrometer (LTQ-FT Ultra, Thermo Finnigan, San
Jose, USA). Neutral molecules were transferred into an
atmospheric pressure ion funnel and ionized by a SESI
setup as published before (Meier et al. 2012a, c). Detailed
information on the SESI interface as well as on the setup
and construction has been reported elsewhere (Meier et al.
2012b). A small schematic is shown in the supplementary
information (Fig. S1). Breath is introduced into the system
via a disposable non-return valve mouth piece (ACE series,
ACE GmbH, Freilassing, Germany) to prevent saliva from
entering. A Teflon tube is used to transfer breath into the
interface (ID 10 mm, OD 12 mm). For offline analyses,
breath was collected on 100 mg cotton supported by a
Teflon tube. The Teflon tube was placed in the spray unit
after breath was collected. The charging spray unit was
heated to 75 C (less than the boiling point of the solvent
mixture used) with three heating cartridges (Probag
Wa¨rmetechnik AG, Niederbuchsiten, Switzerland) to pre-
vent sample molecules from condensing. Heat transfer
through an aluminum adapter resulted in warming of the
breath interface to roughly 40 C.
The charging spray solvent consisted of a MeOH:H2O
mixture in a 1:1 ratio acidified with 1 % acetic acid, and
three identical sprays were infused at 0.05 mL/min each. A
voltage of 3 kV was applied. The transfer capillary was
held at 250 C. All other parameters were optimized for
maximum ion yield. Mass spectra were collected in scan-
ning mode in the m/z range of 100–500 Da. The resolution
was set to nominally 150,000 and the maximum accumu-
lation time to 100 ms. The linear trap was set to maximum
transmission and the ion transfer was tuned and calibrated
by the use of a self-made calibration mix. The best ion
transmission was obtained in the range of 200–400 Da.
2.4 Validation of mass resolution and accuracy
The system was optimized for best ion transmission, res-
olution and mass accuracy. Mass calibration and tuning of
all relevant parameters were performed by the standard ion
source and the calibration solution. The ion funnel inter-
face was then installed and optimized on the inlet of the
LTQ-FT instrument. This optimization was previously
described in more detail by Meier et al. (2012b). Mass
resolution and accuracy were frequently checked by ana-
lyzing known background signals. The current setup for
these experiments achieved a mass resolution of 102,460
and a mass accuracy of \0.9 ppm. The latter value was
evaluated at the signal of dioctylphthalate, exact mass
391.284835 ([M?H]?), measured mass 391.2845. On the
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lower end of the mass spectrum m/z 130.1590 ([M?H]?)
was used, most likely dioctylamine, which showed an
experimental mass accuracy of \4.4 ppm. These back-
ground signals were used to check the calibration during
the study, to recognize, for example, any form of calibra-
tion shift. The calibration itself was always based on the
calibrants injected by ESI prior to each measurement ser-
ies. For calculations and further data interpretation, an
accuracy of 5 ppm and a resolution of 100,000 were
assumed, based on the data found for the background sig-
nals used (dioctylphthalate and dioctylamine).
2.5 Data acquisition and library searches
Data acquisition was controlled by the Xcalibur 2.0 soft-
ware (Thermo Fisher Scientific, Waltham, MA, USA). The
conditions were in general the same as published by Meier
et al. recently, if not indicated otherwise (Meier et al.
2012b).
For library searches, ChemSpider (http://www.chem
spider.com), the Human Metabolite Database (HMDB
http://www.hmdb.ca) and METLIN (http://metlin.scripps.
edu/) were used. ChemSpider is a very general database,
which covers many structures from many sources (about 28
Million structures, Dec 2012). METLIN covers metabolites
from any organism (about 65,000 structures, Dec 2012),
whereas HMDB is focused on human metabolites only
(40,000 structures, Dec 2012).
3 Results and discussion
3.1 Discerning metabolites in exhaled breath
Although the investigation of breath is comparable to that
of other matrices, the direct ionization combined with the
real-time nature of our acquisition requires new data
interpretation steps. Since no separation is performed prior
to ionization (e.g. chromatography), the use of high-reso-
lution mass spectrometry is a good approach to separate
potential metabolites. In the mass range of 50–500 m/z, up
to 5,700 signals are detected in each breath stroke. This
includes isotopic patterns, solvent clusters, contaminants,
and exhaled metabolites. Figure 1 shows the mass spectra
of humidified air, clean breath, breath after smoking,
chewing gum, and drinking coffee. Only a fraction of these
signals are actually related to metabolites or exhaled
exogenous compounds.
Figure 2 shows the general strategy we propose for
distinguishing exhaled endogenous metabolites and exog-
enous compounds with ambient ionization mass spec-
trometry. The strategy is divided into three main steps, as
shown in Fig. 2a–c; this is discussed in the following
paragraph. This strategy is based on the real-time data
evaluation of exhaled breath and not on chromatographic
separation, therefore it represents a new approach for dis-
covering metabolites. In step A (Fig. 2a) the mass spec-
trum is collected breath-by-breath and all the detected
masses are listed. For each breath stroke a mass spectrum is
collected, as shown in Fig. 1. It is not possible to perform
background subtraction to distinguish exhaled metabolites
from background signals: the signal intensity in SESI is
strongly influenced by humidity and sample gas flow rate
(Dillon et al. 2010; Sinues et al. 2012). Temperature, flow
rate and the level of humidification of breath are neither
readily reproducible nor stable; as such, a subtraction of the
signals that appear in the background from those observed
in a breath stroke is not helpful as this might actually cause
Fig. 1 SESI mass spectra of exhaled breath. Mass spectra of real-
time detection of a humidified air, b normal breath, c breath after
drinking coffee, d chewing gum and e smoking a cigarette are shown.
Each spectrum represents the summarized spectra of one breath
stroke. The intensity is different since the duration of a measurement,
the humidification as well as the temperature are not always identical
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artifacts. In addition to this, no reference blank exists for
endogenous metabolites in breath. Moreover, there is no
pure instrumental blank. In classical LC–MS metabolo-
mics, the appearance of signal in a blank sample would be
classified as a contaminant; this is not possible in real-time
breath analysis. Nevertheless, recording a blank (such as
humidified air) is necessary to assist the identification of
unknown metabolites during the breath-by-breath evalua-
tion. Step B of our interpretation strategy (Fig. 2b) takes
this new aspect into account.
To keep the number of signals manageable for manual
interpretation we reduced the total number of signals to 500
(the 500 strongest signals). Many of these signals had
matches in open access databases such as METLIN or
HMDB. This process was very fast and provided approx-
imately 130 hits for 25 masses. These 25 masses repre-
sented good candidates for further investigation and their
limited number entailed that it was feasible that further
manual interpretation could be applied. Nevertheless, we
recognized that many unknown metabolites could not be
processed if only database hits were used. As such, the 30
most intense signals that did not produce any hits in the
databases were also added for further investigations. For
positive ion mode, a total of 55 signals underwent further
processing in order to identify metabolites, exhaled exog-
enous compounds or internal background signals by ana-
lyzing their real-time pattern.
The real-time pattern of an exhaled compound is sig-
nificantly influenced by its origin. This is due to the
physiology of breathing and the method of sampling. Since
the volunteer in our experiment was asked to exhale for as
long as possible and rest in between breath strokes, each
stoke appeared quite similar and represented the whole
lung volume. The first 150 mL of exhaled air is the so-
called dead space, which consists of freshly inhaled air that
has very little or no interaction with the lung surface
(alveoli, bronchiole). Approximately 500 mL of the
exhaled air after this is the normally exhaled volume (for a
calm person) that already contains some metabolites, but
also a high fraction of room air. This volume was slightly
enhanced as the result of the fact that the subject took a
deeper inhalation and was holding breath for a few sec-
onds, which will lead to the accumulation of metabolites.
The residual air (about 5 L in total) originated from deep
inside the lung and contained the main fraction of exhaled
metabolites (tidal breath). This physiological fact directly
affected the real-time breath spectrum. This aspect is
problematic for quantitative studies in breath, but very
helpful for untargeted metabolite studies. An exhaled
metabolite should rise slowly during one breath stroke or
remain at least stable, whereas an exogenous compound
should start with a high value before being gradually
diluted by the air from the deeper lung. This pattern should
be reproducible from breath stroke to breath stroke, since
some background signals may behave in an unpredictable
fashion.
Figure 3 depicts the example of two ions (m/z 391.2850
and 293.1795), which regularly appeared in exhaled breath
in experiments over the course of weeks. The signal of
m/z 391.2850 represented a trend that indicates a gradual
dilution by the breath from the deeper lung, whereas
Fig. 2 Strategy for assignment to exhaled compounds. The spectra of
one or several breath strokes are averaged, which will provide about
signals 5,700 for clean breath. This mass list collected in section (a) is
the basis for further investigations. By eliminating the smallest signals
(\40 counts/scan) a list of about 500 signals is generated. This mass
list is either matched directly with databases or analyzed according to
the exhaled breath-by-breath pattern. About 25 compounds that
provided significant database hits and the 30 most intense signal
without hits were process further. These about 55 signals were
processed according to the breath-by-breath behavior. About 30
compounds were identified as exogenous exhaled compounds or
exhaled metabolites. The sum formulae of these compounds were
calculated and crosschecked by databases and the isotopic pattern.
About 26 exhaled compounds were identified by the use of this
strategy. If there is a conclusive biological hit in a database, this
marker may be investigated directly in a targeted study. If there is no
hint for identity according the accurate mass, the identification has to
be performed with complementary methods prior to a targeted study.
In section (c) this additional identification loop, which may include
offline sampling and classical HPLC–MS, is shown
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m/z 293.1795 remained stable, which indicates a metabo-
lite. Humidified air (before the first stroke in Fig. 3) was
used as a baseline; signals that are intensity enhanced by
humidity and flow could be compared and identified with
this baseline. Additional patterns of putative endogenous
and exogenous compounds are shown in the supplementary
Fig. S2–S4. Using the breath-by-breath pattern analysis for
the 55 extracted masses (positive ion mode), about 21
potential metabolites and 5 potentially exogenous exhaled
compounds could be distinguished. The remaining of sig-
nals were most likely contaminations originating from
inside the mass spectrometer or from the electrospray
solvent; they did not show a reproducible pattern. This
interpretation step, which was performed manually in the
present case, can potentially be fully automated and could
be applied to all signals detected in the first step. This
would also allow the detection of metabolites of very low
intensity.
The qualified list of compounds derived from steps A
and B in the strategy (Fig. 2) is confirmed and refined by
identification algorithms to identify compounds detected
by high-resolution mass spectrometers. Kind and Fiehn
(2007) introduced a strategy to identify metabolites mea-
sured by HPLC–MS, called the ‘‘seven golden rules’’.
These rules were adapted to the data obtained by our
method to generate and confirm sum formulae. The sum
formulae were determined and validated by help of the
associated isotopic patterns. The 26 signals listed in
Table 1 represent the ‘‘survivors’’ from this process in
positive ion mode, including the suggested sum formula.
The table also shows the numbers of hits in the database.
The signals in negative ion mode, which were evaluated in
the same way, are also listed. The main difference is that in
negative ion mode, fewer signals were detected (\600 in
total). This strategy (Fig. 2a, b) provides a first list of
potential exhaled metabolites and exogenous compounds.
The final step of the process is to identify the exhaled
compounds (Fig. 2c). A few of the compounds listed were
already matched with hits in the database. As an example,
lactate (m/z 89.0244) was identified with some confidence,
since it has been reported in breath before (Marek et al.
2010; Martinez-Lozano and Fernandezde la Mora 2008).
Some exogenous exhaled compounds, such as the dioc-
tylphthalate, a very common plasticizer, were also easily
identified (m/z 391.2845). Other compounds provide hits
that were theoretically possible, but have never been
found in exhaled breath. One such candidate was
m/z = 352.2850, which could be capnine (according to
METLIN). Capnine is a well-known metabolite of the lipid
metabolism of bacteria (Abbanat et al. 1985; White 1984).
Either there is an unknown metabolic pathway in humans
which produces this compound, or bacteria living in the
mouth cavity or the lung produce it. In the future, these hits
need to be identified and substantiated, e.g., by comparison
with blood levels, by the use of authentic standards, and by
working with a statistically relevant number of volunteers.
This may be work for the compounds already known,
however many of the compounds listed did not result in
Fig. 3 Breath-by-breath patterns from the real-time extracted ion
chromatogram. The dotted lines separate long exhalation phases from
brakes between measuring breath samples. At the beginning of the
experiment, humidified air was blown into the system. The top graph
shows the extracted ion chromatogram for m/z 391.285. It most likely
represents an exogenous contaminant, probably dioctylphthalate. The
breath strokes enhance the signal and transport the phthalate into the
ion source. M/z = 293.1795 could refer to the singly protonated ion
of thioperamide, which may represent a metabolite
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any conclusive database hits. Even if there were a few hits,
such as for m/z 302.1934, none of them were published
before in a biological context, which makes it interesting,
but also challenging, for further studies.
Even at high resolution, mass spectrometric methods are
not sufficient to positively identify unknown compounds,
since isomers are not separated and the mass spectrum is
limited to one-dimensional information. Therefore it is
necessary to add at least one additional dimension to
identify such molecules. In a study by Gamez et al., a new
metabolite of valproic acid was found, and it was possible
to identify this metabolite through the use of collision
induced fragmentation (CID) in a high-resolution instru-
ment (Gamez et al. 2011). This new metabolite could be
identified since the signal was very intense and therefore
the MS/MS approach was feasible. However, the signals of
virtually all metabolites detected with our configuration
were too weak and the mass selection of the linear trap was
Table 1 Masses with estimated metabolites or contaminants in real time breath are listed
m/z Elemental composition Chem spider METLIN HMDB Pattern Possible assignment Off-line
Positive mode
130.1590 C8H19N 110 1 7 E Octylamine Yes
168.1242 C9H15N2O 17 0 0 M No
173.1654 C9H20ON2 421 0 0 M No
203.2133 C11H26N2O 36 0 0 M No
212.1509 C9H17N5O 56 1 0 M No
214.1801 C12H23NO2 488 0 92 M No
216.1961 C12H25NO2 229 1 37 M 12-Amino-dodecanoic acid No
217.2287 C12H28N2O 17 0 0 M No
223.0980 C13 H10 N4 172 0 0 E No
230.2117 C13H27NO2 185 4 13 M No
231.2430 C13H30N2O 158 0 0 M No
256.1693 C17H21NO 1,947 4 4 M No
264.1448 C11H21NO6 56 0 8 M No
268.1550 C14H21NO4 1,043 0 7 M No
279.1590 C16H22O4 925 7 19 E No
296.1854 C16H25NO4 657 2 6 M No
302.1934 C11H23N7O3 1 0 1 M No
302.2333 C16H31NO4 0 0 6 M No
302.2696 C17H35NO3 15 0 0 M No
324.2176 C18H29NO4 371 0 2 M No
340.2641 C23H33NO 139 1 0 M Evocarpine Yes
352.2514 C17H37NO4S 3 1 0 M Capnine Yes
372.3112 C21H41NO4 59 2 11 M Yes
391.2849 C24H38O4 368 115 7 E Dioctylaphtalate Yes
398.3625 C24H47NO3 31 1 0 M No
437.3408 C30H44O2 65 1 0 M No
Negative mode
89.0244 C3H6O3 31 8 34 M Lactate N.A.
105.0192 C3H6O4 11 3 7 M Glyceric acid N.A.
112.9854 C4H2O4 11 0 1 M N.A.
119.0348 C4H8O4 80 13 19 E N.A.
135.0297 C4H8O5 17 5 13 M Erythronic acid N.A.
149.0453 C5H10O5 129 15 30 M Ribose N.A.
158.9908 C5H4O6 5 0 1 M N.A.
177.0558 C10H10O3 641 17 22 M N.A.
179.0558 C6H12O6 221 24 45 E N.A.
The hits found in METLIN database are shown
N.A. not analyzed
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not sufficiently narrow (mass window was too broad) to
perform MS/MS on them. As seen in Table 1, some of the
signals observed differed in mass by less than 0.1 Da,
which would mean that both would fragment together in a
MS/MS experiment. Therefore, a different approach is
needed to collect additional structural information for these
compounds. Since there is no other method that is able to
access compounds of low volatility in breath in real time,
only an off-line method can deliver comparable data. In
order to extend our initial strategy, it was necessary to
combine it with an off-line method to allow the combina-
tion of our new method with classical metabolomics tools.
Therefore Teflon tubes, filled with cotton were used and
tested. The absorbed breath was desorbed using humidified
air and directly measured in the ion funnel SESI interface.
Using cotton, only a few compounds were successfully
trapped, nevertheless it shows that the combination of real-
time and off-line detection using SESI is possible. The
result of this experiment is shown in Table 1 last column.
Since absorbance materials are always selective, it is very
helpful to make sure that the compound of interest is
trapped successfully by using the same ionization method.
Therefore, this intermediate step between real-time and
off-line evaluation is quite useful. A compound that is
trapped successfully, is easily analyzed further by the use
of classical metabolic methods such as HPLC or UPLC–
MS and finally identified by the use of authentic standards,
if available (an example of how this can be done is shown
in the supplementary information).
3.2 Discerning exogenous compounds in exhaled
breath
Exogenous compounds in this context are understood as
exhaled compounds that are not metabolites, but enter into
the breath from elsewhere, usually from the surrounding
room air. It important that further study designs take into
account the influence of external contaminations on the
exhaled breath measured, which is also influenced by the
subject’s living habits, as well ass the behavior and sur-
roundings prior to the experiment. The influence of exog-
enous compounds on breath was tested after the volunteer
chewed gum, drank coffee, or smoked a cigarette. Fig-
ure 1c–e shows the mass spectra of breath after consuming
Table 2 Compounds found by
external contamination are
listed which are clearly
identified as related to the
contamination
The compound names refer to
hits in METLIN
N.A. not analyzed
m/z Elemental
composition
Possible assigment Detected
offline
Chewing gum
236.1149 C12H15O3N2 N.A.
264.1404 C15H21NOS N.A.
264.1469 C14H219O3N2 N.A.
288.1495 C19H17N3 N.A.
292.1781 C16H23O3N2 N.A.
297.1952 C19H24N2O N.A.
353.2599 C23H32N2O N.A.
Coffee
80.0497 C5H5N Pyridine N.A.
Cigarette
108.0811 C7H9N Benzylazanium/o-toluidine/N-methyl-aniline No
122.0968 C8H11N Phenylethylamine/N-ethylaniline/xylidine/N,N-
dimethylaniline
No
136.1124 C9H13N Dextroamphetamine/2,4,5-trimethylaniline No
148.1125 C10H13N No
150.1281 C10H15N N-Butylaniline/phentermine/2,6-diethylaniline No
160.1125 C11H13N No
163.1234 C10H14N2 Nicotine Yes
164.1438 C11H17N 3 Hexylpyridine No
176.1438 C12H17N No
184.1700 C11H21NO No
188.1438 C13H17N Yes
204.1751 C14H21N No
207.1497 C12H18N2O No
221.1653 C13H20N2O No
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these products. Table 2 shows the additional signals
observed in exhaled breath after the consumption. Strong
signals were observed after the subject smoked, which may
originate from compounds in tar. These homologs have
been previously reported for cigarette smoke (side stream
as well as main stream) and are also found as environ-
mental contaminants (Stabbert et al. 2003; Torikaiu et al.
2005). Nevertheless, to our knowledge, there is no study
yet which proves that these compounds are directly exhaled
after smoking. Moreover, we have already observed a
similar mass spectral pattern in a study by APCI–MS in
2011 (Berchtold et al. 2011), but did not further identify the
signals. Some of the exhaled compounds from cigarette
smoke are plotted as time dependent signals in Fig. 4. The
patterns observed indicate that they originate from within
the respiratory system (at least the mouth cavity). The
signal m/z = 122.0968 (Fig. 4, top) disappeared quite fast.
Nicotine (m/z = 163.1234), as the main active compound
and the only clearly identified hit in all the databases, was
very clearly observed. Free nicotine in the blood flow is
potentially exhaled, which fits the known pharmacokinetic
behavior (Kardani et al. 2010). It appears that the other
signals, which may refer to metabolites, are partially sup-
pressed after smoking. As soon as the main exogenous
compounds disappeared, these signals re-appeared again.
For example, the signal at m/z 168.1242 demonstrates this
behavior (Fig. 4 bottom). This signal is an unknown
metabolite. For chewing gum these effects were even
stronger. There were a few strong signals that suppressed
all other potential metabolite peaks (Fig. 1c). In the
experiment with chewing gum, none of the signals were
identified: there was no hit in any of the databases that
could be matched with an aroma or other well-known
compound, thus no assignment is proposed. Only sum
formulae and isotopic patterns were confirmed and are
listed in Table 2. Coffee does not influence the exhaled
pattern as much as chewing gum or smoke. In the experi-
ment with coffee, pyridine was identified, a well-known
compound that can be expected in the breath of people who
drink coffee (Meier et al. 2012b). All these results are
Fig. 4 The real-time extracted ion chromatograms from several m/
z values after smoking is shown. The ion at m/z 122.0968 represents
an aromatic amine (likely a mixture of isomers), which is directly
exhaled after smoking and fades away fast. M/z 163.1234 is nicotine,
which shows the expected kinetics. M/z 168.1242 is an unidentified
signal, which has a pattern that suggests an exhaled metabolite. The
disappearance of this signal right after smoking implies ion
suppression, probably due to the high signal intensities of the tar
compounds. This suppression could take place during ionization,
although it is also possible that the high level of contamination in the
respiratory system directly suppresses the release of this compound.
The insets show zooms of the individual breath-strokes, which are not
very well resolved in the overview graph. The dashed line in the
extracted ion chromatogram indicates the noise level
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summarized in Table 2. For cigarette smoke, the use of
cotton tubes for offline detection was tested as well. Nic-
otine was detected in offline-mode SESI, whereas the tar
compounds were not detected. Nicotine as well as some of
the tar compounds were also detected by UPLC–MS after
extracting the tube with methanol (see supplementary).
4 Concluding remarks
The analysis of the breath-by-breath pattern enables to dis-
tinguish between exhaled exogenous compounds, exhaled
metabolites, and background signals. Signals that are iden-
tified as endogenous are further assigned to possible com-
pounds using database matching (Fig. 3, supplementary Fig.
S2–S4). To identify signals that do not provide a conclusive
hit, the combination with off-line analysis will become
important. The use of cotton-filled Teflon tubes shows that
in principle it is possible to use off-line SESI ionization (also
for studies where patient are not able to move in front of the
instrument) as well as classical HPLC–MS or UPLC–MS to
identify unknowns. For instance, the compounds listed in the
table should be rigorously identified by employing orthog-
onal methods (such as UPLC–MS) and by the use of
authentic reference standards if available.
Contamination by large concentrations of exogenous
compounds was found to suppress the ionization of
endogenous exhaled compounds. For example, we found
that smoking even 90 min prior to an experiment still
resulted in suppression effects. For the successful analysis
of endogenous compounds in exhaled breath by SESI, it
must thus be assured that a subject does not smoke, chew
gum, use mouth wash, etc. for about 2 h before the mea-
surements are carried out.
Finally, the strategy presented here might help to find
and identify many new metabolites in exhaled breath. The
whole process can be automated, which allows systematic
screening for unknown metabolites. This proposed strategy
is independent of the ionization method or instrument used
as, long as the time resolution, mass resolution and sensi-
tivity are sufficient. Real-time breath analysis is thus a
promising new method to perform metabolomics studies.
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